<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.4" extension="2015-08-01"/>
  <id root="8d26c6f0-e946-46d2-b443-666164e916d8"/>
  <code code="11488-4" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Consult note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Addiction Medicine Consultation — Elvis Presley</title>
  <effectiveTime value="20260717120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="22c7552b-1f55-4dba-a2d6-7eb932625648"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="48aea9e5-f8f1-471c-a8a2-41f396e41ba4" extension="HR-ML003-SYN"/>
      <id root="2.16.840.1.113883.4.1" extension="000-03-4417"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Elvis</given><family>Presley</family></name>
        <administrativeGenderCode code="M" codeSystem="2.16.840.1.113883.5.1" displayName="Male"/>
        <birthTime value="19870108"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="20260717120000-0500"/>
    <assignedAuthor><id root="ad47ed4d-690e-463b-91bd-cb842bcf41dc"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rosalind</given><family>Eberhardt-Mensah</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="20260717120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="ad47ed4d-690e-463b-91bd-cb842bcf41dc"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rosalind</given><family>Eberhardt-Mensah</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <inFulfillmentOf>
    <order><id root="cd8e8158-1078-4bf8-9c22-0e062d358110"/></order>
  </inFulfillmentOf>
  <documentationOf>
    <serviceEvent classCode="PCPR"><effectiveTime><low value="20260717"/><high value="20260717"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="ad47ed4d-690e-463b-91bd-cb842bcf41dc"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rosalind</given><family>Eberhardt-Mensah</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="d62ea69b-9433-4e64-b0e2-55c536084365"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>One-week review, seen the same day by addiction medicine: diagnoses, buprenorphine started in the office, the benzodiazepines combined into one, the sleep study and home blood pressure results</originalText></code>
      <effectiveTime><low value="20260717"/><high value="20260717"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="ad47ed4d-690e-463b-91bd-cb842bcf41dc"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rosalind</given><family>Eberhardt-Mensah</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.1" extension="2014-06-09"/>
    <code code="42349-1" codeSystem="2.16.840.1.113883.6.1" displayName="Reason for referral (narrative)"/>
    <title>Reason for Referral</title>
    <text><paragraph>Long-term prescription opioids and benzodiazepines from five prescribers, with fatigue, weight gain, constipation, daytime sleepiness and high blood pressure, in a 39-year-old touring singer who wants to change how he takes his medicines. Please assess for substance use disorders and advise on medication for opioid use disorder and a safe benzodiazepine plan. [S]</paragraph><paragraph>Urgency: Within one week, on the day of his one-week primary care review, at his request before a Las Vegas engagement in five weeks. [S]</paragraph><paragraph>Questions for the consultant:</paragraph><list listType="ordered"><item>Does he meet DSM-5-TR criteria for opioid and sedative use disorders, and how severe?</item><item>Should he start buprenorphine, and how: in the office or at home, standard or low-dose start?</item><item>How should the two benzodiazepines be managed alongside buprenorphine, and at what taper pace?</item><item>What monitoring do you advise (urine testing, monitoring program, visit frequency, naloxone)?</item><item>How should care be planned around a Las Vegas engagement and a tour this autumn?</item></list></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Mr. Presley, a 39-year-old singer, is seen at the request of Dr. Ashby-Nakagawa. He began opioids about five years ago for back and neck pain from performing, and benzodiazepines for sleep after late shows. Over time he took more than prescribed, found more than one prescriber, and felt sick and craved them when he ran short; a hospital stay some years ago withdrew him from opioids, and he restarted within months. He has never injected or used illicit drugs and does not drink. For the past week he has taken only this clinic&apos;s prescriptions. He last took hydromorphone about 18 hours ago and oxycodone about 20 hours ago, as planned, and is in mild to moderate withdrawal. He took diazepam and alprazolam last night. He has a Las Vegas engagement in five weeks and a tour after it and wants to start treatment now. [S]</paragraph><paragraph>Historical basis. These claims are historical evidence, not findings from a modern examination.</paragraph><list><item>Elvis Aron Presley was born in a two-room house in Tupelo, Mississippi, on January 8, 1935; his family moved to Memphis when he was 13. [D]</item><item>He made his first record in 1953, became a national star in 1956, served in the Army in West Germany from 1958 to 1960, and by the 1970s performed long engagements in Las Vegas and toured constantly. In 1974 he played Las Vegas from January 26 to February 9, toured through much of March, including four shows in Memphis on March 16 and 17 and a recorded show there on March 20, played Lake Tahoe from May 16 to 26, toured again in mid-June, and took a few weeks off at Graceland from early July. [D]</item><item>From October 15 to November 1, 1973, he was treated at Baptist Memorial Hospital in Memphis under an assumed name; at the 1981 trial of his physician, an internal medicine specialist who reviewed the records testified that the consulting physicians were &quot;withdrawing him from narcotic drugs.&quot; [D]</item><item>He had glaucoma, including an episode of acute angle-closure glaucoma in 1971, and was under the care of one ophthalmologist from 1971 on. [D]</item><item>It was believed that he neither smoked nor drank alcohol. [D]</item></list><paragraph>10 later historical claims are omitted because they describe events after the index age. See the teaching note.</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="d1ca0e9f-e0fd-4ebe-ba0b-37e4625a0603"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260710"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="4fc16996-4b58-4561-b1bf-7f95ea0209ab"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Hydromorphone 4 mg oral tablet, prescribed elsewhere as one tablet every four to six hours as needed for back and neck pain; taking about five a day (20 mg, 100 MME); continued by this clinic only, at the verified dose and seven days at a time, until the addiction medicine consultation</td><td>Up to five tablets a day; seven-day supply</td><td>Oral route</td><td>2026-07-10 to 2026-07-17</td><td>completed</td><td>S</td></tr><tr ID="medication-2"><td>Oxycodone 10 mg and acetaminophen 325 mg oral tablet, prescribed by a second prescriber; taking about three a day (45 MME); continued by this clinic only, seven days at a time, until the consultation</td><td>Up to three tablets a day; seven-day supply</td><td>Oral route</td><td>2026-07-10 to 2026-07-17</td><td>completed</td><td>S</td></tr><tr ID="medication-3"><td>Diazepam 10 mg oral tablet, one tablet three times daily, prescribed elsewhere for anxiety; continued by this clinic only, seven days at a time</td><td>One tablet three times daily; seven-day supply</td><td>Oral route</td><td>2026-07-10 to 2026-07-17</td><td>completed</td><td>S</td></tr><tr ID="medication-4"><td>Alprazolam 1 mg oral tablet, up to three a day as needed, prescribed by a fourth prescriber while on tour; continued by this clinic only, at the verified dose, seven days at a time</td><td>Up to three tablets a day; seven-day supply</td><td>Oral route</td><td>2026-07-10 to 2026-07-17</td><td>completed</td><td>S</td></tr><tr ID="medication-5"><td>Phentermine 37.5 mg oral tablet each morning, prescribed by a weight clinic; stopped today because of high blood pressure and his glaucoma</td><td>Stopped</td><td>Oral route</td><td>2026-07-10 to 2026-07-10</td><td>completed</td><td>S</td></tr><tr ID="medication-6"><td>Latanoprost 0.005% eye drops, one drop in each eye at bedtime, prescribed by his ophthalmologist</td><td>One drop in each eye at bedtime</td><td>Ophthalmic route</td><td>2026-07-10</td><td>active</td><td>S</td></tr><tr ID="medication-7"><td>Naloxone 4 mg nasal spray, one spray into one nostril for a suspected overdose, repeated in the other nostril after two to three minutes if needed; two-pack, with a second for the tour bag</td><td>One spray for a suspected overdose; call 911</td><td>Nasal route</td><td>2026-07-10</td><td>active</td><td>S</td></tr><tr ID="medication-8"><td>Polyethylene glycol 3350, 17 g powder in a glass of water once daily</td><td>17 g in water once daily</td><td>Oral route</td><td>2026-07-10</td><td>active</td><td>S</td></tr><tr ID="medication-9"><td>Senna 8.6 mg oral tablet, two tablets at bedtime</td><td>Two tablets at bedtime</td><td>Oral route</td><td>2026-07-10 to 2026-08-07</td><td>completed</td><td>S</td></tr><tr ID="medication-10"><td>Buprenorphine 8 mg and naloxone 2 mg sublingual film, two films (16 mg) under the tongue once daily, which may be split into one film twice daily; started in the office at the consultation; seven-day supplies at first, from this clinic only</td><td>Two films once daily, or one film twice daily</td><td>Sublingual route</td><td>2026-07-17</td><td>active</td><td>S</td></tr><tr ID="medication-11"><td>Diazepam 10 mg oral tablet, one tablet four times daily (40 mg a day), replacing both diazepam 10 mg three times daily and alprazolam; held steady until buprenorphine is stable</td><td>One tablet four times daily; seven-day supply</td><td>Oral route</td><td>2026-07-17 to 2026-08-07</td><td>completed</td><td>S</td></tr><tr ID="medication-14"><td>Amlodipine 5 mg and valsartan 160 mg oral tablet, one tablet daily</td><td>One tablet daily</td><td>Oral route</td><td>2026-07-17</td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="8da0b7d2-e528-443f-90e1-3a76420c6064"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260710"/><high value="20260717"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="4" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="897702" codeSystem="2.16.840.1.113883.6.88" displayName="hydromorphone hydrochloride 4 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="5879bfe2-56af-47a9-bfa3-71287eb6fcbf"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="R53.83" codeSystem="2.16.840.1.113883.6.90" displayName="Other fatigue"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="1d1f5b81-dd41-4728-af6e-ee5162109404"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260710"/><high value="20260717"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="8" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="1049214" codeSystem="2.16.840.1.113883.6.88" displayName="acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="01c3f9f9-655b-4d77-93cc-2ee2d7db52be"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="R53.83" codeSystem="2.16.840.1.113883.6.90" displayName="Other fatigue"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="bddd24fe-1bd4-4c2d-ad7c-7b0b90c068e5"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260710"/><high value="20260717"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="8" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="197589" codeSystem="2.16.840.1.113883.6.88" displayName="diazepam 10 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="41996528-aa47-4251-8b42-d8f17a59f23b"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="R53.83" codeSystem="2.16.840.1.113883.6.90" displayName="Other fatigue"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="7da02dd6-96fc-49d7-b419-60f65a8c7998"/>
      <text><reference value="#medication-4"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260710"/><high value="20260717"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="8" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="197321" codeSystem="2.16.840.1.113883.6.88" displayName="alprazolam 1 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="bc3c75c7-a7f4-40d9-8784-c359e5115034"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="R53.83" codeSystem="2.16.840.1.113883.6.90" displayName="Other fatigue"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="f548f000-bfdc-4bd9-8a11-070a10495978"/>
      <text><reference value="#medication-5"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260710"/><high value="20260710"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="803353" codeSystem="2.16.840.1.113883.6.88" displayName="phentermine hydrochloride 37.5 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="0653a60b-a7ae-4373-8167-ecf9ac244be0"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E66.811" codeSystem="2.16.840.1.113883.6.90" displayName="Obesity, class 1"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="e40e778d-cb9e-42fc-a17c-24ea36ed5788"/>
      <text><reference value="#medication-6"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260710"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38287" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Ophthalmic route"/>
      <doseQuantity value="1" unit="[drp]"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="314072" codeSystem="2.16.840.1.113883.6.88" displayName="latanoprost 0.05 MG/ML Ophthalmic Solution"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="b951f4a1-2663-461c-860c-ec3f9a3e7fae"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="H40.63X1" codeSystem="2.16.840.1.113883.6.90" displayName="Glaucoma secondary to drugs, bilateral, mild stage"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="3f89e9d2-a233-47bc-9691-01fc31b1fc06"/>
      <text><reference value="#medication-7"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260710"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38284" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Nasal route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="1725059" codeSystem="2.16.840.1.113883.6.88" displayName="naloxone hydrochloride 40 MG/ML Nasal Spray"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="ef9dfc9b-a1c1-424f-8e42-766c2f99fafd"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="R53.83" codeSystem="2.16.840.1.113883.6.90" displayName="Other fatigue"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="9945b022-a244-4ebf-b1a1-926809f7a1d8"/>
      <text><reference value="#medication-8"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260710"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="17" unit="g"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="876193" codeSystem="2.16.840.1.113883.6.88" displayName="polyethylene glycol 3350 17000 MG Powder for Oral Solution"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="6fd4615e-9cf1-48c3-91cd-dfccbe62109f"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="R53.83" codeSystem="2.16.840.1.113883.6.90" displayName="Other fatigue"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="a6e027cd-cabb-401d-8e35-201b884c7747"/>
      <text><reference value="#medication-9"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260710"/><high value="20260807"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="2"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="312935" codeSystem="2.16.840.1.113883.6.88" displayName="sennosides, USP 8.6 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="d0eea086-43ef-4c02-85a2-24e0be949e37"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="R53.83" codeSystem="2.16.840.1.113883.6.90" displayName="Other fatigue"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="3379e166-e17f-4d19-b3da-8102cc1cc8a5"/>
      <text><reference value="#medication-10"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260717"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38300" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Sublingual route"/>
      <doseQuantity value="2"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="1010604" codeSystem="2.16.840.1.113883.6.88" displayName="buprenorphine 8 MG / naloxone 2 MG Sublingual Film"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="ae655d9c-328b-48c1-be68-71054a12fa78"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="F11.20" codeSystem="2.16.840.1.113883.6.90" displayName="Opioid dependence, uncomplicated"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="6bf2a659-6451-42af-b111-8c864e487bb1"/>
      <text><reference value="#medication-11"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260717"/><high value="20260807"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="6" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="197589" codeSystem="2.16.840.1.113883.6.88" displayName="diazepam 10 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="915629a0-4363-4ed9-9233-51cdab3e19a5"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="F13.20" codeSystem="2.16.840.1.113883.6.90" displayName="Sedative, hypnotic or anxiolytic dependence, uncomplicated"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="df82a533-8dfc-4901-8fdb-de084b323512"/>
      <text><reference value="#medication-14"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260717"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="722134" codeSystem="2.16.840.1.113883.6.88" displayName="amlodipine 5 MG / valsartan 160 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="e1b971d4-d740-44ab-9735-a915626fbd51"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I10" codeSystem="2.16.840.1.113883.6.90" displayName="Essential (primary) hypertension"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Fatigue, weight gain of about 14 kg in two years, constipation with a bowel movement every five to seven days, loud snoring with daytime sleepiness, and high blood pressure readings, in a man taking two opioids, two benzodiazepines and an appetite suppressant from five prescribers; under evaluation with addiction medicine, a sleep study and home blood pressure readings</td><td>resolved</td><td>confirmed</td>
    <td>R53.83</td><td>S — Synthetic presenting problem anchored to the documented prescribed drugs and weight gain; superseded when the consultation and tests made the diagnoses.</td>
  </tr>
  <tr ID="problem-2">
    <td>Obesity, class 1 (BMI 32.5), with prediabetes (hemoglobin A1c 5.8%); recorded without stigma; weight gain began with long touring schedules, night eating after shows and an appetite suppressant that stopped working</td><td>active</td><td>confirmed</td>
    <td>E66.811</td><td>S — Synthetic modern diagnosis anchored to his documented weight gain.</td>
  </tr>
  <tr ID="problem-3">
    <td>Glaucoma secondary to steroids, both eyes, mild stage, after an acute angle-closure episode treated years ago; intraocular pressure controlled on latanoprost under his ophthalmologist; anticholinergic and sympathomimetic drugs to be avoided</td><td>active</td><td>confirmed</td>
    <td>H40.63X1</td><td>S — Synthetic modern diagnosis anchored to his documented glaucoma and the retrospective interpretation of it as steroid-induced; not a claim about his real eyes.</td>
  </tr>
  <tr ID="problem-4">
    <td>Opioid use disorder, severe, with prescription opioids from more than one prescriber (seven DSM-5-TR criteria, tolerance and withdrawal counted because the opioids were not taken as prescribed); on buprenorphine from the consultation; synthetic modern episode linked to his documented withdrawal from narcotic drugs and prescribed painkillers</td><td>active</td><td>confirmed</td>
    <td>F11.20</td><td>S — Synthetic modern diagnosis made at the addiction medicine consultation; person-first language; not a claim about his real diagnosis.</td>
  </tr>
  <tr ID="problem-5">
    <td>Sedative, hypnotic, or anxiolytic use disorder (benzodiazepines), moderate (five DSM-5-TR criteria), with two benzodiazepines from two prescribers; combined into diazepam and tapering slowly; synthetic modern episode linked to his documented prescribed sedatives</td><td>active</td><td>confirmed</td>
    <td>F13.20</td><td>S — Synthetic modern diagnosis made at the consultation; not a claim about his real diagnosis.</td>
  </tr>
  <tr ID="problem-6">
    <td>Hypertension, stage 2, confirmed by a home average of 146/94 a week after stopping phentermine; ECG and urine albumin normal</td><td>active</td><td>confirmed</td>
    <td>I10</td><td>S — Synthetic modern diagnosis confirmed with home readings, anchored to his documented hypertension.</td>
  </tr>
  <tr ID="problem-7">
    <td>Obstructive sleep apnea, moderate (apnea-hypopnea index 26 an hour, central apnea index 4, oxygen nadir 80% on in-laboratory polysomnography), worsened by opioids and benzodiazepines; on CPAP</td><td>active</td><td>confirmed</td>
    <td>G47.33</td><td>S — Synthetic modern diagnosis from a synthetic sleep study.</td>
  </tr>
  <tr ID="problem-8">
    <td>Opioid-induced constipation (Rome IV), improving after the change to buprenorphine; no alarm features</td><td>active</td><td>confirmed</td>
    <td>K59.03</td><td>S — Synthetic modern diagnosis anchored to his documented blockage of the colon; not a claim about megacolon.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="efcff5e1-624a-411e-a826-58f4d11a5163"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260710"/><high value="20260717"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="06453dbb-5c69-4a33-a8e4-f786b9fd0ab4"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260710"/><high value="20260717"/></effectiveTime>
          <value xsi:type="CD" code="R53.83" codeSystem="2.16.840.1.113883.6.90" displayName="Other fatigue"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="b0f217ad-c05e-47c7-8a5d-9e7bb1af62ef"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260710"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="13787e35-8096-4f75-a1de-856657ddc076"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260710"/></effectiveTime>
          <value xsi:type="CD" code="E66.811" codeSystem="2.16.840.1.113883.6.90" displayName="Obesity, class 1"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="e171f73b-a78b-48fc-b456-092f0d6cd326"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260710"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="c98a0952-ff9a-4e9e-8534-e81424996a06"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260710"/></effectiveTime>
          <value xsi:type="CD" code="H40.63X1" codeSystem="2.16.840.1.113883.6.90" displayName="Glaucoma secondary to drugs, bilateral, mild stage"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="f633b5f5-0bce-4aec-aea6-b2771929582b"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260717"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="e8ae6f14-f1ef-4d74-902d-86a13f594892"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-4"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260717"/></effectiveTime>
          <value xsi:type="CD" code="F11.20" codeSystem="2.16.840.1.113883.6.90" displayName="Opioid dependence, uncomplicated"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="94bbffa9-284c-4c13-9dcc-9d1f3cb8538d"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260717"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="5f18996b-eb6a-460b-973d-e35afbea059d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-5"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260717"/></effectiveTime>
          <value xsi:type="CD" code="F13.20" codeSystem="2.16.840.1.113883.6.90" displayName="Sedative, hypnotic or anxiolytic dependence, uncomplicated"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="d412f145-b881-483c-89bf-ee03901329ab"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260717"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="30bd0653-f9e2-4d25-9292-c63b93148a5f"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-6"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260717"/></effectiveTime>
          <value xsi:type="CD" code="I10" codeSystem="2.16.840.1.113883.6.90" displayName="Essential (primary) hypertension"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="d6f0b060-9055-4ec7-a743-6ebc3c430677"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260717"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="c48498dc-e55b-49e5-ac40-9479fa80d29e"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-7"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260717"/></effectiveTime>
          <value xsi:type="CD" code="G47.33" codeSystem="2.16.840.1.113883.6.90" displayName="Obstructive sleep apnea (adult) (pediatric)"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="f5d3c677-ebed-4835-bbcb-f945039f2883"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260717"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="37437a9b-ae3d-4756-a999-f586d0c66f0f"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-8"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260717"/></effectiveTime>
          <value xsi:type="CD" code="K59.03" codeSystem="2.16.840.1.113883.6.90" displayName="Drug induced constipation"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 2026-07-17; see the referring visit&apos;s Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Restless, yawning; blood pressure 146/94, pulse 102, temperature 37.0 °C</td></tr><tr><td>Eyes</td><td>Pupils 5 mm and reactive; lacrimation</td></tr><tr><td>Skin</td><td>Piloerection; sweating; no injection marks</td></tr><tr><td>Neurological</td><td>Mild tremor of the outstretched hands; alert and oriented</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section nullFlavor="NI">
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1"/>
    <title>Results</title>
    <text><paragraph>No results recorded at this visit.</paragraph></text>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.8"/>
    <code code="51848-0" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation note"/>
    <title>Assessment</title>
    <text><list listType="ordered"><item>Opioid use disorder, severe (F11.20). Seven DSM-5-TR criteria: larger amounts than intended, unsuccessful efforts to cut down, much time spent obtaining prescriptions, craving, continued use despite physical problems, tolerance and withdrawal, which count here because the opioids were not taken as prescribed. Buprenorphine lowers the risk of overdose and death and fits a touring life better than methadone, which needs daily clinic dosing. A standard start is suitable because his opioids are short-acting and he is already in moderate withdrawal; a low-dose start would be chosen for someone who cannot tolerate withdrawal or is on methadone. [S]</item><item>Sedative, hypnotic, or anxiolytic use disorder (benzodiazepines), moderate (F13.20). Five criteria, including withdrawal. Abrupt stopping risks seizures. The 2025 joint guideline allows a switch to a single longer-acting benzodiazepine, advises against tapering during other major changes, and suggests reductions of about 5 to 10% every two to four weeks, adjusted to symptoms. Taking a benzodiazepine is not a reason to withhold buprenorphine, but the combination raises the risk of sedation and slowed breathing, especially with sleep apnea. [S]</item><item>Obstructive sleep apnea (G47.33). Moderate obstructive sleep apnea with a small central component; CPAP is important while he takes buprenorphine and diazepam, and no additional night sedative should be used. [S]</item></list><paragraph>Data reviewed: Dr. Ashby-Nakagawa&apos;s intake note and the prescription drug monitoring program report (five prescribers, three pharmacies, about 145 MME a day with two benzodiazepines). DAST-10 7, AUDIT-C 0, PHQ-9 8, GAD-7 9. The structured safety assessment. Liver tests mildly raised; ECG normal with a QTc of 436 ms. In-laboratory polysomnography three days ago: apnea-hypopnea index 26 an hour, central apnea index 4. Point-of-care urine test today: hydromorphone, oxycodone and benzodiazepines; no fentanyl. COWS 12. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.10" extension="2014-06-09"/>
    <code code="18776-5" codeSystem="2.16.840.1.113883.6.1" displayName="Plan of care note"/>
    <title>Plan of Treatment</title>
    <text><list><item>Start buprenorphine with naloxone in the office today at COWS 12: 4 mg, then 4 mg after an hour if withdrawal persists; 16 mg daily from tomorrow, adjusted up to 24 mg for cravings or withdrawal. [S]</item><item>Stop hydromorphone and oxycodone today and take back the remaining tablets; no full-agonist opioid from any prescriber. [S]</item><item>Combine diazepam and alprazolam into diazepam 10 mg four times daily (40 mg a day); no taper step until buprenorphine has been stable for two to three weeks, then reduce by about 10% every four weeks or so, pausing for engagements, illness or withdrawal symptoms; CBT for anxiety and insomnia. [S]</item><item>Naloxone at home and in the tour bag, with people around him trained; no alcohol, no other sedatives, and CPAP every night. [S]</item><item>A single prescriber and one named pharmacy, a monitoring program check before each prescription, seven-day supplies for the first month then two weeks, and a urine drug test at the start, about a month later and when doses change. [S]</item><item>Weekly contact for the first month, counseling, and safety review at every visit. [S]</item><item>For engagements and tours: no medication change in the week before, prescriptions sent to one named pharmacy where he will be, weekly video visits, and a written plan for missed doses. [S]</item><item>For acute pain: continue buprenorphine and split the dose, add an NSAID or other non-opioid treatment, and call this clinic before any other prescriber gives an opioid. [S]</item><item>Discussed with Dr. Ashby-Nakagawa, who saw him the same day. The diagnoses and the plan were explained to Mr. Presley without blame; he asked whether buprenorphine would affect his voice or his energy on stage, was told that it should not once the dose is steady, and chose to start today. [S]</item><item>Follow-up: Addiction medicine will see him again in three months or sooner if cravings return or the taper stalls; Dr. Ashby-Nakagawa prescribes and follows him, with weekly contact in the first month. [S]</item></list></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
